Targeting the p53-Family in Cancer and Chemosensitivity: Triple Threat
Journal:
Current Drug Targets
Volume:
11
Page:
667-681
Author(s):
J. Chung and M.S. Irwin
Chemosensitization of Prostate Cancer by Modulating Bcl-2 Family Proteins
Journal:
Current Drug Targets
Volume:
11
Page:
699-707
Author(s):
David Karnak and Liang Xu
Targeting Cellular Proapoptotic Molecules for Developing Anticancer Agents from Marine Sources
Journal:
Current Drug Targets
Volume:
11
Page:
708-715
Author(s):
Xiukun Lin, Ming Liu, Chaoxin Hu and D. Joshua Liao
Targeting Apoptosis Pathway with Natural Terpenoids: Implications for Treatment of Breast and Prostate Cancer
Journal:
Current Drug Targets
Volume:
11
Page:
733-744
Author(s):
Huanjie Yang and Q. Ping Dou
The Role of Notch Signaling Pathway in Epithelial-Mesenchymal Transition (EMT) During Development and Tumor Aggressiveness
Journal:
Current Drug Targets
Volume:
11
Page:
745-751
Author(s):
Zhiwei Wang, Yiwei Li, Dejuan Kong and Fazlul H. Sarkar
Human Arylamine N-Acetyltransferase 1: A Drug-Metabolizing Enzyme and a Drug Target?
Journal:
Current Drug Targets
Volume:
11
Page:
759-766
Author(s):
Fernando Rodrigues-Lima, Julien Dairou, Florent Busi and Jean-Marie Dupret
Inhibitors of the Sphingosine Kinase Pathway as Potential Therapeutics
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
354-367
Author(s):
M.R. Pitman and S.M. Pitson
Targeting CREB for Cancer Therapy: Friend or Foe
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
384-391
Author(s):
X. Xiao, B.X. Li, B. Mitton, A. Ikeda and K.M. Sakamoto
Molecular Pathways in the Progression of Hormone-Independent and Metastatic Prostate Cancer
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
392-401
Author(s):
B. Wegiel, S. Evans, R. Hellsten, L.E. Otterbein, A. Bjartell and J.L. Persson
Recent Advances in Understanding Hormonal Therapy Resistant Prostate Cancer
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
402-410
Author(s):
K.V. Donkena, H. Yuan and C.Y. Young